Cécilia Estrella

This inventor holds 5 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Alzprotect, National Institute of Health and Medical Research, Université De Lille 2 Droit Et Santé. Active years: 2017-2026.

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

National Institute of Health and Medical Research

patents

2 out of 13

Université De Lille 2 Droit Et Santé

patents

4. 1 out of 1

Universite De Lille 2 Droit Et Saute

patent

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12629368 - USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SULPHATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS (2026-05-19),

2. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-09-15),

3. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-01-21),

4. 9714245 - Carboline compounds usable in the treatment of neurodegenerative diseases (2017-07-25),

5. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2017-02-07),

Title: Cecilia Estrella: Innovator in Neurodegenerative Disease Treatment

Introduction

Cecilia Estrella is a prominent inventor based in Lomme, France. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and development of novel compounds.

Latest Patents

Cecilia holds 1 patent for her invention titled "Carboline compounds usable in the treatment of neurodegenerative diseases." This patent relates to a compound according to Formula (A) or a pharmaceutically acceptable salt, solvate, clathrate, hydrate, or polymorph thereof, and its use in medical applications.

Career Highlights

Throughout her career, Cecilia has worked with notable organizations such as Alzprotect and Université de Lille 2 Droit et Santé. Her work has focused on developing therapeutic solutions for complex neurological conditions.

Collaborations

Cecilia has collaborated with esteemed colleagues, including Patricia Melnyk and Pascal Carato, to advance her research and enhance the impact of her inventions.

Conclusion

Cecilia Estrella's innovative work in the treatment of neurodegenerative diseases showcases her dedication to improving healthcare through scientific advancements. Her contributions are paving the way for future breakthroughs in this critical area of medicine.